Increasing levels of EGFR T790M or C-MET expression in plasma ctDNA after short-term EGFR-TKI treatment was closely related to EGFR T790M or C-MET amplification in the post-treatment tumor tissue. The gene discussed is MET; the disease is neoplasm.